These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

311 related articles for article (PubMed ID: 32013699)

  • 1. Stunned and Hibernating Myocardium: Where Are We Nearly 4 Decades Later?
    Kloner RA
    J Am Heart Assoc; 2020 Feb; 9(3):e015502. PubMed ID: 32013699
    [No Abstract]   [Full Text] [Related]  

  • 2. Identification of therapeutic benefit from revascularization in patients with left ventricular systolic dysfunction: inducible ischemia versus hibernating myocardium.
    Ling LF; Marwick TH; Flores DR; Jaber WA; Brunken RC; Cerqueira MD; Hachamovitch R
    Circ Cardiovasc Imaging; 2013 May; 6(3):363-72. PubMed ID: 23595888
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The heart and ischemia: stunned-hibernating myocardium].
    Wutte M; Maurer G
    Wien Klin Wochenschr; 1997; 109 Suppl 1():25-33. PubMed ID: 9173671
    [No Abstract]   [Full Text] [Related]  

  • 4. Characterization of hibernating and stunned myocardium.
    Heusch G; Schulz R
    Eur Heart J; 1997 Jun; 18 Suppl D():D102-10. PubMed ID: 9183618
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ischemically compromised myocardium displays different time-courses of functional recovery: correlation with morphological alterations?
    Haas F; Jennen L; Heinzmann U; Augustin N; Wottke M; Schwaiger M; Lange R
    Eur J Cardiothorac Surg; 2001 Aug; 20(2):290-8. PubMed ID: 11463546
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Current views on stunned and hibernating myocardium].
    Simon K; Czuriga I
    Orv Hetil; 2003 Dec; 144(50):2465-9. PubMed ID: 15067985
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The hibernating myocardium].
    Kirkebøen KA
    Tidsskr Nor Laegeforen; 1995 Jun; 115(16):1934-8. PubMed ID: 7638844
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Left ventricular dysfunction due to the new ischemic outcomes: stunning and hibernation.
    Ferrari R; Ceconi C; Curello S; Benigno M; La Canna G; Visioli O
    J Cardiovasc Pharmacol; 1996; 28 Suppl 1():S18-26. PubMed ID: 8891867
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The basis of chronic ischemic reversible left ventricular dysfunction (hibernating myocardium)].
    Mates M; Veselka J
    Cesk Fysiol; 1999 Feb; 48(1):4-8. PubMed ID: 10377599
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Is viability still viable after the STICH trial?
    Cortigiani L; Bigi R; Sicari R
    Eur Heart J Cardiovasc Imaging; 2012 Mar; 13(3):219-26. PubMed ID: 22080451
    [TBL] [Abstract][Full Text] [Related]  

  • 11. More evidence for the survival benefit of coronary revascularization versus medical therapy in patients with ischemic cardiomyopathy and hibernating myocardium.
    Beller GA
    Circ Cardiovasc Imaging; 2013 May; 6(3):355-7. PubMed ID: 23696583
    [No Abstract]   [Full Text] [Related]  

  • 12. Myocardial viability.
    Birnbaum Y; Kloner RA
    West J Med; 1996 Dec; 165(6):364-71. PubMed ID: 9000857
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Does the extended use of arterial grafts compromise the myocardial recovery after coronary artery bypass grafting in left ventricular dysfunction?
    Jegaden O; Bontemps L; de Gevigney G; Eker A; Montagna P; Chatel C; Itti R; Mikaeloff P
    Eur J Cardiothorac Surg; 1998 Oct; 14(4):353-9. PubMed ID: 9845138
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dobutamine-induced contractile reserve in stunned, hibernating, and scarred myocardium in patients with ischemic cardiomyopathy.
    Schinkel AF; Bax JJ; van Domburg R; Elhendy A; Valkema R; Vourvouri EC; Sozzi FB; Roelandt JR; Poldermans D
    J Nucl Med; 2003 Feb; 44(2):127-33. PubMed ID: 12571199
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Consequences of brief ischemia: stunning, preconditioning, and their clinical implications: part 1.
    Kloner RA; Jennings RB
    Circulation; 2001 Dec; 104(24):2981-9. PubMed ID: 11739316
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Left ventricular dysfunction and disturbed O(2)-utilization in stunned myocardium: influence of ischemic preconditioning.
    Sunderdiek U; Schmitz-Spanke S; Korbmacher B; Gams E; Schipke JD
    Eur J Cardiothorac Surg; 2001 Oct; 20(4):770-6. PubMed ID: 11574223
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Metabolic disarrangement in ischemic heart disease and its therapeutic control.
    Ferrari R
    Rev Port Cardiol; 1998 Sep; 17(9):667-84. PubMed ID: 9834638
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Reversible left ventricular dysfunction in coronary disease (part one): myocardial stunning].
    Vlahović A; Popović A
    Med Pregl; 2000; 53(1-2):39-44. PubMed ID: 10953549
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Evaluation of hibernating myocardium in patients with heart insufficiency].
    La Canna G; Agricola E; Alfieri O
    Ital Heart J Suppl; 2000 Oct; 1(10):1289-97. PubMed ID: 11068710
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Incidence of stunned, hibernating and scarred myocardium in ischaemic cardiomyopathy.
    Hernandez-Pampaloni M; Bax JJ; Morita K; Dutka DP; Camici PG
    Eur J Nucl Med Mol Imaging; 2005 Mar; 32(3):314-21. PubMed ID: 15791441
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.